No Data
No Data
Protara Therapeutics to Present at the TD Cowen 45th Annual Health Care Conference
Express News | Protara Therapeutics Inc : TD Cowen Cuts Target Price to $30 From $50
Protara Therapeutics to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference
Protara Therapeutics Announces 6-Month Data From ADVANCED-2 Trial; Expects New Data Mid-2025, Begins Dosing In THRIVE-3 Trial In H1 2025, Awaits Results For STARBORN-1 Trial By End Of H1 2025.
Protara Highlights Recent Updates and Anticipated 2025 Milestones
Protara Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference